Home › Overweight › Louisiana
Overweight clinical trials in Louisiana
24 studies for Overweight are looking for participants at sites in Louisiana.
Cities in Louisiana
- Baton Rouge11 studies
- New Orleans5 studies
- Monroe4 studies
- Shreveport4 studies
- Lafayette3 studies
- Metairie3 studies
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- BRCR Global Louisiana, Gretna
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT07837973A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Pennington Biomedical Research Center, Baton Rouge
- IMA Clinical Research Monroe-Main, Monroe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Southern Clin Research, Zachary
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07668414A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Velocity Clinical Research, Lafayette
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Care Access - New Iberia, New Iberia
- Louisiana Research Center, Shreveport
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Care Access - New Iberia, New Iberia
- Louisiana Research Center, Shreveport
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- IMA Clinical Research Monroe - Armand, Monroe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07392190Impact of Lean Pork on Endothelial Function in Perimenopause
- Pennington Biomedical Research Center, Baton Rouge
RecruitingHealthy volunteers welcome
Ages 40 to 55 · Women · Updated Sep 22, 2026 · NCT06976112A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Care Access - Shreveport 2, Shreveport
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07369011A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Monroe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Care Access - Lake Charles (Bayou Pines), Lake Charles
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Cardiovascular Associates Research, LLC, Covington
- Tandem Clinical Research - Marrero, Marrero
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Clinical Trials Management, LLC d/b/a Flourish Research, Metairie
- IMA Clinical Research Monroe - Armand, Monroe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Baton Rouge
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Baton Rouge
- AURORA-2 Clinical Site, Metairie
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Elevate Clinical Research, Lake Charles
- Nola Care Clinical Research Center, Metairie
- DelRicht Clinical Research, LLC, New Orleans
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Ascension DePaul Health, New Orleans
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351045Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Shreveport
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Velocity Clinical Research - Baton Rouge, Baton Rouge
- Tandem Clinical Research - Marrero, Marrero
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684235A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Pennington Biomed Res Ctr, Baton Rouge
RecruitingPhase 3
Ages 8 to 18 · All sexes · Updated Aug 31, 2026 · NCT07253285Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Pennington Biomedical Research Center, Baton Rouge
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Aug 27, 2026 · NCT07575399Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Baton Rouge
RecruitingPhase 3
Ages 18 to 79 · All sexes · Updated Aug 10, 2026 · NCT07654361Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding
- Pennington Biomedical Research Center, Baton Rouge
RecruitingHealthy volunteers welcome
Ages 18 to 42 · All sexes · Updated Apr 8, 2026 · NCT04583514International Weight Control Registry
- Pennington Biomedical Research Center, Baton Rouge
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 19, 2024 · NCT04907396From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.